CIPLA's weekly performance was disappointing, with a return of -2.11% and a max drawdown of the same magnitude, indicating a decline in value. The stock's volatility was relatively low at 6.8%, but its Sharpe Ratio of -1.65 suggests that the return was not sufficient to compensate for the risk taken. Compared to its peers, CIPLA underperformed SUNPHARMA and DIVISLAB, but outperformed GRASIM. Overall, the stock was moderately risky this week.

[Volatility: 6.8%]